- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Immunosuppressive phenolic compounds from Hydnora abyssinica A. Braun
© Koko et al. 2015
Received: 2 January 2015
Accepted: 3 November 2015
Published: 9 November 2015
Hydnora abyssinica (HA) A. Braun is an endemic Sudanese medicinal plant traditionally used as anti-inflammatory and against many infectious diseases. However, it proved to be very rich in phenols and tannins, so the present study was undertaken to investigate the immunomodulatory potential of the whole plant ethanolic extract and its isolated compounds.
Lymphocyte proliferation, chemiluminescence and superoxide reduction assays were used for immunomodulatory evaluation. While, MTT (3–(4, 5-dimethylthazol-2-yl)-2, 5-diphenyl tetrazonium bromide) test was performed on 3 T3 cell line clone in order to evaluate the cytoxicity effect of the extracts and isolated compounds of phenolic derivatives which were carried out by chromotographic techniques.
Catechin, (1), tyrosol (2) and benzoic acid, 3, 4, dihydroxy-, ethyl ester (3) compounds were isolated from HA ethanolic extract which revealed potent immunosuppressive activity against reactive oxygen species from both polymorph nuclear cells (PMNs) (45–90 % inhibition) and mononuclear cells (MNCs) (30 -65 % inhibition), T lymphocyte proliferation assay (70–93 % inhibition) as well as potent inhibitory effect against superoxide production (42–71 % inhibition) at concentrations of 6.25–100 μg/mL. Catechin (1) was found the most potent immunosuppressive agent among all constituents examined.
These results can support the traditional uses of H. abyssinica extracts as anti-inflammatory and immunosuppressive and further investigations of the mode of action and other pharmacological studies are highly desirable.
Immunosuppressive drugs are commonly prescribed to prevent the rejection of transplanted organs, or to treat chronic inflammatory diseases, such as ulcerative colitis, neutropenia, Crohn’s disease, rheumatoid arthritis and connective tissue disorders [1–3].
From centuries people has been using the herbal medicines for the treatment of various diseases [4, 5]. Up today, ethnomedicine still plays the axial role in the search and development of new drugs . Similarly for many developing countries, herbal drugs have a major importance based on indigenous knowledge, cultural acceptability and affordability . Indeed, it is estimated that about 90 % of Sudanese population depend mainly on herbal medicines for the primary treatment of various types of diseases, ranging from simple disorders to more chronic pathologies such as cancers .
H. abyssinica belongs to the family Hydronaceae (Leafless and rootless parasite). The plant is locally known as “Tartous”, and distributed in central Sudan. In Sudanese folk medicine, the whole plant aqueous extract is used for the treatment of swellings, tonsillitis and dysentery . The plant aqueous extract had shown considerable molluscicidal activities against Bulinus truncatus and Biomphalaria pfeifferi . Recently preliminary phytochemical analysis of H. abyssinica has shown the latter to be very rich in phenols and tannins .
In spite of its ethnobotanical uses, there is a paucity of pharmacological and chemical data on Sudanese tartous. To this effect, the present study was therefore undertaken to investigate the immunomodulatory activity of the whole plant ethanolic extract and its isolated secondary compounds through lymphocyte proliferation, chemilumenscence and superoxide reduction assays. MTT cytotoxicity against 3 T3 cell line carried out for plant ethanolic extracts and the isolated compounds.
The selected plant species was collected from its natural habitat in the central Sudan around Acacia sp. Voucher specimens was identified by Dr. Wai’l S. Abdalla and Mr. Haidar Elsidig of Herbarium of Medicinal and Aromatic Plants Research Institute (MAPRI), Khartoum, Sudan, where the specimen was also deposited (MO22–07).
Preparation of the crude extract
Hundred grams of whole plant material was air-dried under the shed, grounded, and extracted by triple soaking in 80 % ethanol at room temperature for 3 days. Extracts were obtained by removing the organic solvent under reduced pressures by using rotary evaporator.
Isolation of secondary metabolites (constituents)
UV Spectra were recorded in methanol or chloroform on a Hitachi UV 3200 spectrophotometer. IR Spectra were recorded in CHCl3 or KBr on a Jasco A-302 IR spectrophotometer. The EI MS spectra were recorded on a double focusing mass spectrometer (Varian MAT 311A). HREI MS measurements were performed on a Jeol HX 110 mass spectrometer. The 1H-NMR spectra were recorded on Bruker AC-300 and AM-400 MHz instruments, while 13C-NMR spectra were recorded at 100 and 125 MHz. Multiplicities of the carbon signals were determined by DEPT 90° and 135° experiments. 1H-NMR and 13C-NMR chemical shifts were reported in δ (ppm) and coupling constants (J) were measured in Hz.
Column chromatography was performed on A silica gel 60 (70–230 and 240–300 mesh sizes, E. Merck), Diaion HP-20 Resin and Sephadex LH-20 were used. Final purification of some compounds was achieved by preparative recycling HPLC (model LC-908) (JAI) and the columns used were L-80 or H-80 (YMC, Co. Ltd) at appropriate flow rates (4 mL/min) using equivalent combinations of MeOH and H2O. Pre-coated silica gel TLC plates (E. Merck, F254) were used for evaluating the compounds. TLC plates were viewed under ultraviolet light at 254 nm for fluorescence quenching spots and at 366 nm for fluorescent spots. Ceric-sulphate in 10 % H2SO4 spraying reagent was used for staining the compounds on TLC.
Isolation and purification of compounds
The crude ethyl acetate fraction (14 g) was subjected to column chromatography eluted with 50 % chloroform/n-hexane with gradient increase of chloroform up to 100 and methanol up to 100 %. Ten fractions were obtained. On repeated flash column chromatography using chloroform/methanol system for fraction (8), compound 1 was obtained by elution column with 15 % methanol/chloroform.
Fractions 4 and 5 were loaded on reverse phase Sephadex column LH-20 starting by high polarity 100 % distilled water and followed by a gradient decrease with methanol until 100 % methanol, from each fraction 3 sub fractions were obtained, the sub fraction (2) of each were subjected to recycling preparative high performance liquid chromatography (HPLC), using mobile phase of water-methanol (1:1) on L-80 ODS column (reverse phase). The purification of compounds 2 and 3 was conducted by using repeated recycling HPLC.
Isolation of Human Polymorphoneutrophils (PMNs) and Mononuclear Cells (MNCs)
Heparinized blood was obtained by vein puncture aseptically from healthy volunteers (25–38 years age). The consent was obtained from the healthy donors for the use of their blood in this study. The buffy coat containing PMNs and MNCs was collected by dextran sedimentation and the cells were isolated after the Lymphocyte Separation Medium (LSM) density gradient centrifugation. MNCs were separated gently by collecting them from the plasma- ficoll interface using pasteur pipette, while PMNs were collected from the tube base. Cells were washed twice and suspended in Hank’s Balance Salt Solution [Ca and Mg free] (HBSS−−), pH 7.4. Neutrophils were purified from RBCs contamination using hypotonic solution. Cells were adjusted to their required concentration using Hank’s Balance Salt Solution containing Ca and Mg (HBSS++). The study was approved by the local Ethics Committee (MAPRI Ethics Committee, National Centre for Research, Khartoum, Sudan).
Luminol or lucigenin–enhanced chemiluminescence assay were performed as described by Helfand et al.  and Haklar et al. . Briefly, 25 μL of PMNCs (1 × 106) and MNCs (5 × 106) cells were incubated with 25 μL of serially diluted plant extract with concentration ranges between 6.25 to 100 μg/mL. while concentrations of 3.13 to 50 μg/mL were used for pure compounds. Predinsalone was used as reference drug (control positive) with concentration of 10 μg/mL. Control wells (control negative) received HBSS++ and cells but no extract. Tests were performed in white 96 wells plates in triplicate for each concentration and controls, which were incubated at 37 ° C for 30 min in the thermostated chamber of the luminometer. Opsonized zymosan-A or PMA 25 μL, followed by 25 μL luminol (7 × 10−5M) or lucigenin (0.5 mM) along with HBSS++ was added to each well to obtain a 200 μL volume/well. The luminometer results were monitored as chemiluminescence RLU (relative light unit), with peak and total integral values set with repeated scans at 30 s intervals and one second points measuring time.
T-cell proliferation assay
Superoxide anion radical scavenging activity
MTT cytotoxicity test
Serial dilutions of compound was prepared in a 96-well flat bottomed plate (Nalge Nunc, Inter. USA). The outer wells of the plate were filled with 250 μL of in-complete culture medium, except the last row 6 middle wells (B - G), which were used for the negative control receiving 50 μL of culture medium and 2 μL of sterile 0.5 % Triton X.
To the rest of the plate, 50 μL/wells (CCM) were added and 30 μL more were added to second column wells (B – G) that were used as first compounds dilution wells. To the first dilution wells in the row, 20 μg of compound suspension were added to the 80 μL. Compounds were then serially diluted by two-fold dilution from well B3 till B11 by transferring 50 μL to the next well after proper mixing. From the last dilution wells (B-11), 50 μL were discarded. Each compound was tested in triplicate. Cell suspension in a complete culture medium containing 2.5 × 105/mLwas properly mixed, and 150 μL of it were transferred into each well of the plate. The plate was covered and placed in 5 % CO2 incubator at 37 °C for three-five days (72–120 h). On the third/fifth day, the supernatant was removed from each well without detaching cells. MTT stock (5 mg/mL) was prepared earlier in 100 mL PBS. MTT suspension was vortexed and kept on magnetic stirrer until all MTT dissolved. The clear suspension was filter sterilized with 0.2 μm Millipore filter and stored at 4 °C or –20 until use. MTT was diluted in a culture medium (1:3.5) and brought to room temperature. To each well of the 96-well plates, 50 μL of diluted MTT were added. The plate was incubated further at 37 ° C for 2 to 3 h in CO2 incubator. MTT was removed carefully without detaching cells, and 200 μL of DMSO were added to each well. The plate was agitated at room temperature for 15 min then read at 540 nm using microplate reader.
All data are presented as means ± standard deviation of the mean. Statistical analysis for all the assays results were done using student’s t-test. Significance was attributed to probability values P ≤ 0.05 or P ≤ 0.001 in some cases.
It is a well known polyphenolic secondary metabolite, isolated for the first time from H. abyssinica, ethyl acetate (bulk amount 2 g) fraction by using 25 mm diameter column chromatography (silica gel) in chloroform methanol system, purified from sub fraction column 8 in 50 % ethyl acetate/chloroform.
Physical status: White crystals
Yield: 6.7 X 10−2%
Rf: 0.7 (15 % Chloroform/methanol)
Melting point: 241–243 °C.
[α]D25:−45 °(c = 0.1, CH3OH)
IR (KBr) νmax cm−1: 3420 (OH), 1646 (C = C).
1H NMR (CD3OD, 300 MHz, δ): 6.83 (1H, d J = 1.7 Hz, H-2′), 6.75 (1H, d J = 8.1 Hz, H-5′), 6.72 (1H, d J = 1.8 Hz, H-6′), 5.9 (1H, d J = 2.2 Hz, H-8), 5.8 (1H, d J = 2.2 Hz, H-6), 4.55 (1H, d J = 7.5 Hz, H-2), 3.98 (1H, dt, J = 7.6 Hz, J = 5.3 Hz H-3), 2.87 (2H, dd, J = 5.5,10.7 Hz H-4).
13C NMR (CD3OD, 100 MHz, δ): 157.5 (C-7), 157.3 (C-5), 156.0 (C-9), 146.2 (C-3′ and 4′), 132.2 (C-1′), 120.0 (C-6′), 116.3 (C-2′), 100.8 (C-10), 96.3 (C-6), 95.5 (C-8), 82.2 (C-2), 68.8 (C-3), 28.5 (C-4)
HREI MS: m/z 290.272 (calcd 290.0790 for C15H14O6)
EI MS (rel.int. %): m/z 290 (16), 167 (3), 152 (44), 139 (100), 124 (17), 110 (9), 77 (14), 69 (26).
2-(4 hydroxyphenyl) ethanol (Tyrosol) (2)
It is a simple phenol derivative compound isolated from H. abyssinica ethyl acetate fraction by using recycling P-HPLC (1:1) water: methanol L-80 ODS reversed phase column.
Physical status: Colorless needles
Yield: 2.7 X 10−4%
Rf: 4.7 (10 % chloroform/methanol)
Melting point: 85–86 °C.
IR (CH3OH) νmax cm−1: 3380, 3140 (OH), 1590 (C = C)
1H NMR (CD3OD, 400 MHz, δ): 7.0 (1H, d, J = 2.1 Hz, H-2 and 6), 6.7 (1H, m, H-3 and H-5), 3.6 (2H, t, J = 7.2 Hz, H-8), 2.7 (2H t, J = 7.2 Hz, H-7).
13C NMR (CD3OD, 100 MHz, δ): 159.2 (C-4), 131.3 (C-1), 130.8 (C-3 and 5), 116.1 (C-2 and C-6), 64.0 (C-8), 40.0 (C-7).
HREI MS: m/z 138.66 (calcd 138.0681 for C8H10O2)
EI MS (rel.int. %): m/z 138 (39), 121 (32), 107 (100), 93 (8), 77 (44).
Benzoic acid, 3, 4, dihydroxy- ethyl ester (3)
It is benzoic acid and phenol derivative, isolated from H. abyssinica ethyl acetate fraction by using recycling P-HPLC (1:1) water: methanol L-80 ODS reversed phase column.
Physical status: Colorless crystal
Yield: 3.4 X 10−4%
Rf: 6.5 (10 % chloroform/methanol)
Melting point: 130–135 °C.
IR (KBr) νmax cm−1: 3660 (OH), 1765 (C = O), 1587 (C = C), 1250 (C-O)
1HNMR (CD3OD, 400 MHz, δ): 7.4 (1H, dd, J = 8.8 Hz, J = 1.0 Hz, H-5), 6.7 (1H, d, J = 8.0 Hz, H-2), 4.3 (2H, m, H-8), 1.3 (3H, m, Me-9).
13C NMR (CD3OD, 100 MHz, δ): 168.4 (C-7), 151.8 (C-1), 146.2 (C-6), 123.5 (C-3), 122.8 (C-4), 117.4 (C-2),115.8 (C-5), 61.6 (C-8), 14.7 (C-9).
HREI MS: m/z 182.176 (calcd 182.0579 for C8H10O2)
EI MS (rel.int. %): m/z 182 (35), 153 (17), 137 (100), 109 (45), 77 (52).
T-cell proliferation assay
Superoxide anion radical scavenging activity
MTT cytotoxicity test
MTT reduction cytotoxic assay for evaluation of H. abyssinica and its isolated compounds for their inhibition % against 3T3 cell line
Conc. in μg/mL
17.8 + 3.3
17.2 + 3.7
15.8 + 5.1
12.4 + 4.2
14.4 + 4.1
14.2 + 2.8
12.5 + 4.3
11.5 + 3.5
10.8 + 3.6
12.1 + 3.1
11.4 + 4.1
10.2 + 2.7
8.1 + 2.8
4.0 + 1.3
11.9 + 3.8
8.7 + 2.3
1.4 + 0.3
3.4 + 0.4
4.7 + 1.1
66.7 + 11.6
Since immemorial time plants have been used as an alternative therapy and has stood the test of time. Indeed, many medicinal plants are traditionally used to control unregulated immune stimulation in the cases of anaphylactic shock , inflammatory response, asthma, etc. [16, 17].
During the present investigation, the ethanolic extract of H. abyssinica whole plant showed a significant suppression towards the immune response activation which was assayed by oxidative burst chemiluminescence for both polymorph nuclear cells (PMNs) (45–90 % inhibition) and mononuclear cells (MNCs) (30–65 % inhibition) activated with SOZ. However, in the second assay, T- cell proliferation activity was inhibited significantly (67–97 % inhibition) with all tested concentrations (6.25–100 μg/mL). Also these concentrations were found to be of a significant inhibition for superoxide free radicals (42 to 72 % inhibition). Superoxide radicals scavenging assay was conducted to evaluate immunsupressive activity due the fact that all reactive oxygen species play a major role in the long-term complications of immune-related diseases [18, 19]. However, in the present work, SOZ was used for the stimulation phagocytic cells for superoxide and others reactive oxygen species production. Luminol is characterized by its ability to enter the cell and reacts with intracellular reactive oxygen species (ROS) [20, 21].
The above study on H. abyssinica ethanolic extract encourage further investigation on the plant for the isolation of secondary metabolites, responsible of these activities. Interestingly, these three well known phenolic compounds were isolated for the first time from H. abyssinica. All of these compounds showed suppression of oxidative burst (79–95 % inhibition) for the highest concentration 50 μg/mL and 5–30 % inhibition for the lowest concentration (3.2 μg/mL). All of them revealed potent inhibition for T-cell proliferation (94–98 % inhibition) for the highest concentration (50 μg/mL) and (66–83 % inhibition) for the lowest concentration (3.2 μg/mL). Also they showed inhibition for superoxide production (82–87 %). Results reported from the present study are consistent and in line with the previous observation of Wang et al. . They indicated that aromatic compounds are extremely active in suppressing immune responses in both in-vitro and in-vivo.
Catechin (1) was found the most potent immunosuppressive, among all the compounds tested. Previous studies indicated that catechin is the major polyphenol component of green tea, which has attracted a considerable attention during the last years. It is a powerful antioxidant and the significant activities against all diseases are found associated with ROS productions [23, 24]. Neither H. abyssinica extract nor isolated compounds possesed cytotoxicity activity against 3 T3 cell line. Although they were revealed dose dependant cytotoxic effect but the maximum examined concentration was found of less than 20 % and the IC50 going to be more than 10000 μg/mL, which is 200 times the higher concentrations examined.
In our conclusion we can support the traditional uses of H. abyssinica extracts as anti-inflammatory and immunosuppressive, mainly due to the dominant quantities of catechin (>0.07 %) and other phenolic compounds. Further investigations of the mode of action and other pharmacological studies such like the level of various cytokines in the peripheral blood that is possible to suggest for understand of immune response activity also more experimental analysis for the characterization of immune response activity by the catechin are highly desirable.
This work was supported by a grant from the Islamic Development Bank entitled, Phytochemical, Pharmacological and Toxicological Studies on Medicinal Plants of Sudan and Pakistan. A project for strengthening and twining of the International Center of Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, Pakistan and Medicinal and Aromatic Plants Research Institute (MAPRI), Khartoum, Sudan.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Sany J. Prospects in the immunological treatments of rheumatoid arthritis. Scand J Rheumatol Suppl. 1987;66:129–36.View ArticlePubMedGoogle Scholar
- Bartlett RR, Dimitrijevic M, Mattar T, Zielinski T, Germann T, Rüde E, Thoenes GH, Küchle CC, Schorlemmer HU, Bremer E, Finnegan A, Schleyerbach R. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Actions. 1991;32:10–21.View ArticlePubMedGoogle Scholar
- Loftus CG, Egan LJ, Sandborn WJ. Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease. Gastroenterol Clin North Am. 2004;33:141–69.View ArticlePubMedGoogle Scholar
- Pezzuto JM. Plant – derived anticancer agents. Biochem Pharmacol. 1997;53:121–33.View ArticlePubMedGoogle Scholar
- Mahomoodally FM, Fakim A, Subratty A. Antimicrobial activities and phytochemical profiles of endemic medicinal plants of Mauritius. Pharm Biol. 2005;43:1–6.View ArticleGoogle Scholar
- Heinrich M. Ethnobotany and its role in drug development. Phytother Res. 2000;14:479–88.View ArticlePubMedGoogle Scholar
- Ali H, König GM, Khalid SA, Wright AD, Kaminsky R. Evaluation of selected Sudanese medicinal plants for their in vitro activity against hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory, and for cytotoxicity. J Ethnopharmacol. 2002;83:219–28.View ArticlePubMedGoogle Scholar
- Koko WS, Mesaik MA, Yousaf S, Galal M, Choudhary MI. In vitro immunomodulating properties of selected Sudanese medicinal plants. J Ethnopharmacol. 2008;118:26–34.View ArticlePubMedGoogle Scholar
- El Ghazali GE, El Tohami M, El Egami A, Abdalla W, Galal M. Medicinal Plants of the Sudan Part IV: Medicinal Plants of Northern Kordfan. Khartoum: Medicinal and Aromatic Plants Research Institute; 1997. p. 77.Google Scholar
- Ayoub SM, Yankov L. Potential molluscicides from some tannin-containing plants growing in the Sudan. Fitoterapia. 1985;65:371–3.Google Scholar
- Saadabi AM, Ayoub SM. Comparative bioactivity of hydnora abyssinica a. Braun against different groups of fungi and bacteria. Journal of Medicinal Plants Research. 2009;3:262–5.Google Scholar
- Helfand SL, Werkmeister J, Roder JC. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis. J Exp Med. 1982;156:492–505.View ArticlePubMedGoogle Scholar
- Haklar G, Sayin-Ozveri E, Yüksel M, Aktan AO, Yalçin AS. Different kinds of reactive oxygen. Cancer Lett. 2001;165:219–24.View ArticlePubMedGoogle Scholar
- Nielsen M, Gerwien J, Geisler C, Röpke C, Svejgaard A, Odum N. MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells. Exp Clin Immunogenet. 1998;15:61–8.View ArticlePubMedGoogle Scholar
- Sayyah M, Hadidi N, Kamalinejad M. Analgesic and anti-inflammatory activity of lactuca sativa seed extract in rats. J Ethnopharmacol. 2004;92:325–9.View ArticlePubMedGoogle Scholar
- Akah PA, Ezike AC, Nwafor SV, Okoli CO, Enwerem NM. Evaluation of the anti-asthmatic property of Asystasia gangetica leaf extracts. J Ethnopharmacol. 2003;89:25–36.View ArticlePubMedGoogle Scholar
- Manga HM, Brkic D, Marie DE, Quetin-Leclercq J. In vivo anti-inflammatory activity of Alchornea cordifolia (Schumach. & Thonn.) Mull. Arg. (Euphorbiaceae). J Ethnopharmacol. 2004;92:209–14.View ArticlePubMedGoogle Scholar
- Boynes JW. Role of oxidative stress in the development of complication in diabetes. Diabetes. 1991;40:405–11.View ArticleGoogle Scholar
- Sabu MC, Kuttan R. Antidiabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81:155–60.View ArticlePubMedGoogle Scholar
- Dahlgren C, Briheim G. Comparison between the luminol- dependent chemiluminescence of polymorphonuclear leukocytes and of the myeloperoxidase-HOOH system: influence of pH, cations and protein. Photochem Photobiol. 1985;41:605–10.View ArticlePubMedGoogle Scholar
- Allen RC. Phagocytic leukocytic oxygen activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 1986;133:449–93.View ArticlePubMedGoogle Scholar
- Wang BS, Murdock KC, Lumanglas AL, Damiani M, Silva J, Ruszala-Mallon VM, Durr FE. Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses. Int J Immunopharmacol. 1987;9:733–9.View ArticlePubMedGoogle Scholar
- Lee H, Bae JH, Lee SR. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res. 2004;77:892–900.View ArticlePubMedGoogle Scholar
- Ban JY, Jeon SY, Bae K, Song KS, Seong YH. Catechin and epicatechin from Smilacis chinae rhizome protect cultured rat cortical neurons against amyloidbeta protein (25-35)-induced neurotoxicity through inhibition of cytosolic calcium elevation. Life Sci. 2006;79:2251–9.View ArticlePubMedGoogle Scholar